Nigel Crockett, Ph.D.
Chief Business Officer

Nigel Crockett image


Nigel Crockett, Ph.D., is chief business officer of Bicycle Therapeutics.

Nigel joined Bicycle Therapeutics from Tukan Partners Ltd., which he founded as a consultancy providing hands-on, transactional, commercial expertise for a broad range of biotech clientsfrom around the world. Prior to founding Tukan Partners, Nigel was a member of the management team at Astex, completing 14 deals for the company. Previously, Nigel held commercial and senior management roles at several pharma-biotech companies, including Heptares (now Sosei-Heptares), Microbiotica, Crescendo Biologics, NodThera, Clinical Designs Ltd. and Cantab Pharmaceuticals. In more than 25 years, he built expertise in the licensing of early- and late-stage clinical assets and company financing and has completed more than 50 major deals, establishing industry-leading strategic collaborations in a multitude of key therapeutic areas.He previously chaired the U.K.’s BioIndustry Association, Business Development Working Group.

Nigel received his B.S. in chemistry from the University of Manchester and obtained a Ph.D. in Molecular Biology from Cambridge University.

    Nigel Crockett image